Pacific Biosciences Of California | PACB - Ebitda


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Pacific Biosciences Of California

Pacific Biosciences Of California reported $-91024000 in EBITDA for its fiscal quarter ending in March of 2023.


Ebitda Change
Accelerate Diagnostics AXDX:US USD -15260000 2.09M
Agilent A:US USD 472M 33M
Bruker BRKR:US USD 151.3M 9.9M
Danaher DHR:US USD 2.32B 538M
General Electric GE:US USD 911M 1.35B
Illumina ILMN:US USD 15M 73M
Myriad Genetics MYGN:US USD -32800000 500K
NanoString Technologies NSTG:US USD -37014000 2.7M
Pacific Biosciences Of California PACB:US USD -91024000 10.42M
Quidel QDEL:US USD 180.1M 49.4M
Roche Holding ROG:VX CHF 10.43B 3B
Thermo Fisher Scientific TMO:US USD 2.56B 204M
Waters WAT:US USD 205.58M 112.02M